Will Medicare pay for CAR T-cell therapy?

[ORachel]

Yes, Medicare covers FDA-approved CAR T-cell therapies for eligible patients, but significant out-of-pocket costs are common. Coverage requires the treatment to be FDA-approved for specific cancers (like certain lymphomas and leukemias) and administered at a CMS-certified treatment center. Patients typically face 20% coinsurance under Part B, plus deductibles, which can amount to tens of thousands of dollars.

Medicare's coverage is structured under Part A (inpatient) and Part B (outpatient), depending on where the infusion is administered. The therapy itself, a one-time infusion of genetically modified cells, is covered under Part B. If the patient requires hospitalization for management of severe side effects, those costs fall under Part A.

Key determinants for coverage include:

• FDA Approval: The therapy must be FDA-approved for the patient's specific cancer type.
• Facility Certification: Administration must occur at a healthcare facility enrolled in the FDA's Risk Evaluation and Mitigation Strategy (REMS) program for CAR T-cell therapy.
• Medical Necessity: The treating physician must deem it medically necessary, often after other treatments have failed.

Cost-sharing is a major consideration. Under Medicare Part B, patients are responsible for 20% of the Medicare-approved amount for the drug and administration services, after meeting the Part B deductible ($240 in 2024). There is no annual out-of-pocket maximum for traditional Medicare (Parts A and B). The list price for CAR T-cell therapies often exceeds $400,000, meaning the 20% coinsurance alone could be $80,000 or more.

Coverage Aspect	Details under Traditional Medicare
Therapy Drug Cost	Covered under Part B, subject to 20% coinsurance.
Inpatient Hospital Stay	Covered under Part A, subject to a deductible ($1,632 in 2024) and coinsurance for stays beyond 60 days.
Outpatient Administration	Covered under Part B, subject to 20% coinsurance.
Clinical Trial Routine Costs	Covered by Medicare when therapy is part of a qualified clinical trial.
Major Financial Risk	High out-of-pocket costs due to lack of an annual spending cap on Part B.

Most beneficiaries use supplemental insurance (Medigap) to cover these gaps. Medicare Advantage (Part C) plans are required to cover CAR T-cell therapy if it's covered by Original Medicare, but their cost-sharing structures and provider networks vary significantly. It is critical to contact both Medicare and your supplemental insurer for a pre-service coverage determination before proceeding with treatment.

[OValerie]

As an oncology social worker, I help patients navigate this daily. The short answer is yes, Medicare covers it, but the "how much will I pay?" question keeps people up at night. I always say, "Don't just ask if it's covered—ask how it's covered." Get your oncologist's office to initiate a pre-authorization. Then, call your Medigap or Medicare Advantage plan with the codes they provide. Get the estimate in writing. I've seen coinsurance bills hit $70,000. Without a Medigap Plan G or similar, that debt is devastating. Please, start the financial conversation with your care team as early as possible.

[OConnor]

My husband received CAR T-cell therapy for his lymphoma last year under Medicare. We were relieved it was covered, but the financial process was a second battle. Our hospital's financial counselor was a lifesaver. She explained that because he got the infusion as an outpatient, Part B was primary. We have a Medigap Plan F, which picked up the 20% coinsurance—thank goodness, because that would have been over $60,000. The big lesson? Your supplemental insurance is just as important as your Medicare coverage here. Also, all the pre-testing and the cell collection procedure were billed separately, so watch for those statements. The clinical care was outstanding, but you must be your own financial advocate.

[LucyLynn]

From a hospital administrator's view, coverage is clear but administratively dense. We cannot proceed without a confirmed CMS certification for our facility and a solid pre-authorization. For Medicare patients, the billing is split: the drug itself under Part B, any inpatient stay under Part A. The major delays come from verifying the patient's supplemental coverage. We prioritize this because the drug is so expensive we can't absorb the cost if a patient's coinsurance isn't covered. We advise all Medicare patients: 1) Confirm your facility is certified, 2) Know your Medigap plan details, and 3) Understand that while Medicare pays its share upfront, you will be billed for your portion unless your supplemental plan pays us directly.

[LeBrayden]

Let's break down the cost scenario, plain and simple. Imagine the total approved charge is $450,000.

• Medicare Part B pays 80%: $360,000.
• You owe 20%: $90,000.
• You also owe the Part B deductible ($240). That $90,000 is your responsibility unless you have extra insurance. That's where Medigap steps in. Plans like G and F (for those eligible) cover that 20% coinsurance. If you're on a Medicare Advantage Plan, you might have a co-pay instead of coinsurance—maybe $5,000 or $10,000 per treatment—but you must use in-network providers. My advice? First, call Medicare (1-800-MEDICARE) to confirm the therapy and your facility are covered. Then, immediately call your supplemental insurer. Ask them: "Based on a $450,000 CAR T-cell therapy, what will my out-of-pocket cost be?" Get a reference number for that call. This isn't a regular doctor's visit; it's the most expensive therapy many people will ever encounter, so due diligence is non-negotiable.

[AsherDella]

Let's break down the cost scenario, plain and simple. Imagine the total approved charge is $450,000.

• Medicare Part B pays 80%: $360,000.
• You owe 20%: $90,000.
• You also owe the Part B deductible ($240). That $90,000 is your responsibility unless you have extra insurance. That's where Medigap steps in. Plans like G and F (for those eligible) cover that 20% coinsurance. If you're on a Medicare Advantage Plan, you might have a co-pay instead of coinsurance—maybe $5,000 or $10,000 per treatment—but you must use in-network providers. My advice? First, call Medicare (1-800-MEDICARE) to confirm the therapy and your facility are covered. Then, immediately call your supplemental insurer. Ask them: "Based on a $450,000 CAR T-cell therapy, what will my out-of-pocket cost be?" Get a reference number for that call. This isn't a regular doctor's visit; it's the most expensive therapy many people will ever encounter, so due diligence is non-negotiable.